SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins
Staphylococcus aureus is a successful pathogen that produces a wide range of virulence factors that it uses to subvert and suppress the immune system. These include the bicomponent pore-forming leukocidins. How the expression of these toxins is regulated is not completely understood. Here, we descri...
Gespeichert in:
Veröffentlicht in: | Infection and immunity 2023-04, Vol.91 (4), p.e0053222 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | e0053222 |
container_title | Infection and immunity |
container_volume | 91 |
creator | Anderson, Exene E Dyzenhaus, Sophie Ilmain, Juliana K Sullivan, Mitchell J van Bakel, Harm Torres, Victor J |
description | Staphylococcus aureus is a successful pathogen that produces a wide range of virulence factors that it uses to subvert and suppress the immune system. These include the bicomponent pore-forming leukocidins. How the expression of these toxins is regulated is not completely understood. Here, we describe a screen to identify transcription factors involved in the regulation of leukocidins. The most prominent discovery from this screen is that SarS, a known transcription factor which had previously been described as a repressor of alpha-toxin expression, was found to be a potent repressor of leukocidins LukED and LukSF-PV. We found that inactivating
resulted in increased virulence both in an
model using primary human neutrophils and in an
infection model in mice. Further experimentation revealed that SarS represses leukocidins by serving as an activator of Rot, a critical repressor of toxins, as well as by directly binding and repressing the leukocidin promoters. By studying contemporary clinical isolates, we identified naturally occurring mutations in the
promoter that resulted in overexpression of
and increased repression of leukocidins in USA300 bloodstream clinical isolates. Overall, these data establish SarS as an important repressor of leukocidins and expand our understanding of how these virulence factors are being regulated
and
by S. aureus. |
doi_str_mv | 10.1128/iai.00532-22 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10112191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2788796836</sourcerecordid><originalsourceid>FETCH-LOGICAL-a419t-6ede702bda813b79e0a76e1dd761666bbd3fb8f6d298958fab162187b3bc4a423</originalsourceid><addsrcrecordid>eNp1UclOwzAUtBAIynLjjHIEiRQviWOfEFRsUiWWwtmyHae4JHGwG6T-PYaWCg6cnp5mNG_eDACHCA4RwuzMSjuEMCc4xXgDDBDkLM1zjDfBAELEU57TYgfshjCLa5ZlbBvsEMoJJzgfgMeJ9JPkLiQyeTKdNyE4n7gqmcxl97qonXZa9xHtvYnj0mrXdK417Tx5cN6k1843tp0mY9O_OW1L24Z9sFXJOpiD1dwDL9dXz6PbdHx_cze6GKcyQ3yeUlOaAmJVSoaIKriBsqAGlWVBEaVUqZJUilW0xJzxnFVSIYoRKxRROpMZJnvgfKnb9aoxpY6evKxF520j_UI4acVfpLWvYuo-BIIxN8RRVDheKXj33pswF40N2tS1bI3rg8AFYwWnjNBIPV1StXcheFOt7yAovmoQsQbxXYPAX95OlnQZGixmrvdtjOI_7tHvP9bCPx2RT5OukdI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2788796836</pqid></control><display><type>article</type><title>SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins</title><source>PubMed (Medline)</source><source>MEDLINE</source><source>American Society for Microbiology Journals</source><source>EZB Electronic Journals Library</source><creator>Anderson, Exene E ; Dyzenhaus, Sophie ; Ilmain, Juliana K ; Sullivan, Mitchell J ; van Bakel, Harm ; Torres, Victor J</creator><contributor>Freitag, Nancy E.</contributor><creatorcontrib>Anderson, Exene E ; Dyzenhaus, Sophie ; Ilmain, Juliana K ; Sullivan, Mitchell J ; van Bakel, Harm ; Torres, Victor J ; Freitag, Nancy E.</creatorcontrib><description>Staphylococcus aureus is a successful pathogen that produces a wide range of virulence factors that it uses to subvert and suppress the immune system. These include the bicomponent pore-forming leukocidins. How the expression of these toxins is regulated is not completely understood. Here, we describe a screen to identify transcription factors involved in the regulation of leukocidins. The most prominent discovery from this screen is that SarS, a known transcription factor which had previously been described as a repressor of alpha-toxin expression, was found to be a potent repressor of leukocidins LukED and LukSF-PV. We found that inactivating
resulted in increased virulence both in an
model using primary human neutrophils and in an
infection model in mice. Further experimentation revealed that SarS represses leukocidins by serving as an activator of Rot, a critical repressor of toxins, as well as by directly binding and repressing the leukocidin promoters. By studying contemporary clinical isolates, we identified naturally occurring mutations in the
promoter that resulted in overexpression of
and increased repression of leukocidins in USA300 bloodstream clinical isolates. Overall, these data establish SarS as an important repressor of leukocidins and expand our understanding of how these virulence factors are being regulated
and
by S. aureus.</description><identifier>ISSN: 0019-9567</identifier><identifier>ISSN: 1098-5522</identifier><identifier>EISSN: 1098-5522</identifier><identifier>DOI: 10.1128/iai.00532-22</identifier><identifier>PMID: 36939325</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Exotoxins - genetics ; Exotoxins - metabolism ; Humans ; Leukocidins - genetics ; Mice ; Microbial Pathogenesis ; Molecular Pathogenesis ; Neutrophils ; Special Series: 2022 Midwest Microbial Pathogenesis Conference ; Staphylococcal Infections ; Staphylococcus aureus ; Transcription Factors - metabolism ; Virulence Factors - metabolism</subject><ispartof>Infection and immunity, 2023-04, Vol.91 (4), p.e0053222</ispartof><rights>Copyright © 2023 Anderson et al.</rights><rights>Copyright © 2023 Anderson et al. 2023 Anderson et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a419t-6ede702bda813b79e0a76e1dd761666bbd3fb8f6d298958fab162187b3bc4a423</citedby><cites>FETCH-LOGICAL-a419t-6ede702bda813b79e0a76e1dd761666bbd3fb8f6d298958fab162187b3bc4a423</cites><orcidid>0000-0002-7126-0489</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/iai.00532-22$$EPDF$$P50$$Gasm2$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/iai.00532-22$$EHTML$$P50$$Gasm2$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3175,27901,27902,52726,52727,52728,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36939325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Freitag, Nancy E.</contributor><creatorcontrib>Anderson, Exene E</creatorcontrib><creatorcontrib>Dyzenhaus, Sophie</creatorcontrib><creatorcontrib>Ilmain, Juliana K</creatorcontrib><creatorcontrib>Sullivan, Mitchell J</creatorcontrib><creatorcontrib>van Bakel, Harm</creatorcontrib><creatorcontrib>Torres, Victor J</creatorcontrib><title>SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins</title><title>Infection and immunity</title><addtitle>Infect Immun</addtitle><addtitle>Infect Immun</addtitle><description>Staphylococcus aureus is a successful pathogen that produces a wide range of virulence factors that it uses to subvert and suppress the immune system. These include the bicomponent pore-forming leukocidins. How the expression of these toxins is regulated is not completely understood. Here, we describe a screen to identify transcription factors involved in the regulation of leukocidins. The most prominent discovery from this screen is that SarS, a known transcription factor which had previously been described as a repressor of alpha-toxin expression, was found to be a potent repressor of leukocidins LukED and LukSF-PV. We found that inactivating
resulted in increased virulence both in an
model using primary human neutrophils and in an
infection model in mice. Further experimentation revealed that SarS represses leukocidins by serving as an activator of Rot, a critical repressor of toxins, as well as by directly binding and repressing the leukocidin promoters. By studying contemporary clinical isolates, we identified naturally occurring mutations in the
promoter that resulted in overexpression of
and increased repression of leukocidins in USA300 bloodstream clinical isolates. Overall, these data establish SarS as an important repressor of leukocidins and expand our understanding of how these virulence factors are being regulated
and
by S. aureus.</description><subject>Animals</subject><subject>Exotoxins - genetics</subject><subject>Exotoxins - metabolism</subject><subject>Humans</subject><subject>Leukocidins - genetics</subject><subject>Mice</subject><subject>Microbial Pathogenesis</subject><subject>Molecular Pathogenesis</subject><subject>Neutrophils</subject><subject>Special Series: 2022 Midwest Microbial Pathogenesis Conference</subject><subject>Staphylococcal Infections</subject><subject>Staphylococcus aureus</subject><subject>Transcription Factors - metabolism</subject><subject>Virulence Factors - metabolism</subject><issn>0019-9567</issn><issn>1098-5522</issn><issn>1098-5522</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UclOwzAUtBAIynLjjHIEiRQviWOfEFRsUiWWwtmyHae4JHGwG6T-PYaWCg6cnp5mNG_eDACHCA4RwuzMSjuEMCc4xXgDDBDkLM1zjDfBAELEU57TYgfshjCLa5ZlbBvsEMoJJzgfgMeJ9JPkLiQyeTKdNyE4n7gqmcxl97qonXZa9xHtvYnj0mrXdK417Tx5cN6k1843tp0mY9O_OW1L24Z9sFXJOpiD1dwDL9dXz6PbdHx_cze6GKcyQ3yeUlOaAmJVSoaIKriBsqAGlWVBEaVUqZJUilW0xJzxnFVSIYoRKxRROpMZJnvgfKnb9aoxpY6evKxF520j_UI4acVfpLWvYuo-BIIxN8RRVDheKXj33pswF40N2tS1bI3rg8AFYwWnjNBIPV1StXcheFOt7yAovmoQsQbxXYPAX95OlnQZGixmrvdtjOI_7tHvP9bCPx2RT5OukdI</recordid><startdate>20230418</startdate><enddate>20230418</enddate><creator>Anderson, Exene E</creator><creator>Dyzenhaus, Sophie</creator><creator>Ilmain, Juliana K</creator><creator>Sullivan, Mitchell J</creator><creator>van Bakel, Harm</creator><creator>Torres, Victor J</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7126-0489</orcidid></search><sort><creationdate>20230418</creationdate><title>SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins</title><author>Anderson, Exene E ; Dyzenhaus, Sophie ; Ilmain, Juliana K ; Sullivan, Mitchell J ; van Bakel, Harm ; Torres, Victor J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a419t-6ede702bda813b79e0a76e1dd761666bbd3fb8f6d298958fab162187b3bc4a423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Exotoxins - genetics</topic><topic>Exotoxins - metabolism</topic><topic>Humans</topic><topic>Leukocidins - genetics</topic><topic>Mice</topic><topic>Microbial Pathogenesis</topic><topic>Molecular Pathogenesis</topic><topic>Neutrophils</topic><topic>Special Series: 2022 Midwest Microbial Pathogenesis Conference</topic><topic>Staphylococcal Infections</topic><topic>Staphylococcus aureus</topic><topic>Transcription Factors - metabolism</topic><topic>Virulence Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, Exene E</creatorcontrib><creatorcontrib>Dyzenhaus, Sophie</creatorcontrib><creatorcontrib>Ilmain, Juliana K</creatorcontrib><creatorcontrib>Sullivan, Mitchell J</creatorcontrib><creatorcontrib>van Bakel, Harm</creatorcontrib><creatorcontrib>Torres, Victor J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infection and immunity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, Exene E</au><au>Dyzenhaus, Sophie</au><au>Ilmain, Juliana K</au><au>Sullivan, Mitchell J</au><au>van Bakel, Harm</au><au>Torres, Victor J</au><au>Freitag, Nancy E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins</atitle><jtitle>Infection and immunity</jtitle><stitle>Infect Immun</stitle><addtitle>Infect Immun</addtitle><date>2023-04-18</date><risdate>2023</risdate><volume>91</volume><issue>4</issue><spage>e0053222</spage><pages>e0053222-</pages><issn>0019-9567</issn><issn>1098-5522</issn><eissn>1098-5522</eissn><abstract>Staphylococcus aureus is a successful pathogen that produces a wide range of virulence factors that it uses to subvert and suppress the immune system. These include the bicomponent pore-forming leukocidins. How the expression of these toxins is regulated is not completely understood. Here, we describe a screen to identify transcription factors involved in the regulation of leukocidins. The most prominent discovery from this screen is that SarS, a known transcription factor which had previously been described as a repressor of alpha-toxin expression, was found to be a potent repressor of leukocidins LukED and LukSF-PV. We found that inactivating
resulted in increased virulence both in an
model using primary human neutrophils and in an
infection model in mice. Further experimentation revealed that SarS represses leukocidins by serving as an activator of Rot, a critical repressor of toxins, as well as by directly binding and repressing the leukocidin promoters. By studying contemporary clinical isolates, we identified naturally occurring mutations in the
promoter that resulted in overexpression of
and increased repression of leukocidins in USA300 bloodstream clinical isolates. Overall, these data establish SarS as an important repressor of leukocidins and expand our understanding of how these virulence factors are being regulated
and
by S. aureus.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>36939325</pmid><doi>10.1128/iai.00532-22</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-7126-0489</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0019-9567 |
ispartof | Infection and immunity, 2023-04, Vol.91 (4), p.e0053222 |
issn | 0019-9567 1098-5522 1098-5522 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10112191 |
source | PubMed (Medline); MEDLINE; American Society for Microbiology Journals; EZB Electronic Journals Library |
subjects | Animals Exotoxins - genetics Exotoxins - metabolism Humans Leukocidins - genetics Mice Microbial Pathogenesis Molecular Pathogenesis Neutrophils Special Series: 2022 Midwest Microbial Pathogenesis Conference Staphylococcal Infections Staphylococcus aureus Transcription Factors - metabolism Virulence Factors - metabolism |
title | SarS Is a Repressor of Staphylococcus aureus Bicomponent Pore-Forming Leukocidins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T21%3A38%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SarS%20Is%20a%20Repressor%20of%20Staphylococcus%20aureus%20Bicomponent%20Pore-Forming%20Leukocidins&rft.jtitle=Infection%20and%20immunity&rft.au=Anderson,%20Exene%20E&rft.date=2023-04-18&rft.volume=91&rft.issue=4&rft.spage=e0053222&rft.pages=e0053222-&rft.issn=0019-9567&rft.eissn=1098-5522&rft_id=info:doi/10.1128/iai.00532-22&rft_dat=%3Cproquest_pubme%3E2788796836%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2788796836&rft_id=info:pmid/36939325&rfr_iscdi=true |